<DOC>
	<DOCNO>NCT02161614</DOCNO>
	<brief_summary>The aim study evaluate vascular effect estradiol valerate climacteric woman measure flow-mediated evaluation brachial artery use high resolution ultrasound compare placebo .</brief_summary>
	<brief_title>Vascular Effect Estradiol Valerate Versus Placebo Evaluated Flow-mediated Dilatation Brachial Artery</brief_title>
	<detailed_description>The interruption secretion sex steroid occur menopause , determines change vascular pattern various level . As result , several side effect might appear interfere woman 's quality life health . The use hormone replacement therapy contribute improvement effect . It observe vascular beneficial effect sex steroid premenopausal woman , hormone replacement therapy ( HRT ) climacteric woman , central retinal artery . The objective study evaluate effect estradiol valerate flow-mediated dilation brachial artery .</detailed_description>
	<mesh_term>Dilatation , Pathologic</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<criteria>Women without menstrual cycle within last 12 month follicle stimulate hormone ( FSH ) &gt; 30International Units / Liter Healthy woman Women use drug potential vascular effect within last 1 year Women never use hormone replacement therapy Smoking Blood Pressure &gt; 160/90 mm Hg . Breast endometrial cancer History acute myocardial infarction Diabetes Vaginal bleed origin Hepatic disease thrombophlebitis thromboembolic disorder</criteria>
	<gender>Female</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>hormone replacement therapy</keyword>
	<keyword>Dopplervelocimetry</keyword>
	<keyword>Flow-mediated dilation</keyword>
	<keyword>menopause</keyword>
	<keyword>Estradiol valerate</keyword>
</DOC>